AvardD.SamuëlJ.KnoppersB. M., Paediatric Research in Canada (Montreal:, Éditions Thémis, 2009): at 23.
2.
Id., at 24; AvardD.SamuëlJ.BlackL.GrienerG.KnoppersB. M., Best Practices for Health Research Involving Children and Adolescents: Genetic, Pharmaceutical, Longitudinal Studies and Palliative Care Research, Center for Genomics and Policy, McGill University, 2011, at s. 8.
3.
PatenaudeA. F., “Pediatric Psychology Training and Genetics: What Will Twenty-First-Century Pediatric Psychologists Need to Know?”Journal of Pediatric Psychology28, no. 2 (2003): 135–145.
4.
WilfondB.RossL. F., “From Genetics to Genomics: Ethics, Policy, and Parental Decision-Making,”Journal of Pediatric Psychology34, no. 6 (2009): 639–647.
5.
RigbyH.FernandezC. V., “Providing Research Results to Study Participants: Support Versus Practice of Researchers Presenting at the American Society of Hematology Annual Meeting,”Blood106, no. 4 (2005): 1199–1202, at 1201.
6.
SamuëlJ.KnoppersB. M.AvardD., “Research Involving Children: An Analysis of International and Canadian Norms,” in Avard, supra note 1, at Chap. 1, 1–32.
7.
HensK.NysH.CassimanJ. J.DierickxK., “Children, Biobanks and the Scope of Parental Consent,”European Journal of Human Genetics19, no. 7 (2011): 735–739; KnoppersB. M.AvardD.CardinalG.GlassK. C., “Children and Incompetent Adults in Genetic Research: Consent and Safeguards,”Nature Reviews Genetics3, no. 3 (2002): 221–225.
8.
See Patenaude, supra note 3.
9.
Id.
10.
HensK.NysH.CassimanJ. J.DierickxK., “The Return of Individual Research Findings in Paediatric Genetic Research,”Journal of Medical Ethics37, no. 3 (2011): 179–183.
11.
OrmondK. E.WheelerM. T.HudginsL.KleinT. E.ButteA. J.AltmanR. B.AshleyE. A.GreelyH. T., “Challenges in the Clinical Application of Whole-Genome Sequencing,”The Lancet375, no. 9727 (2010): 1749–1751.
12.
KayeJ.BoddingtonP.de VriesJ.HawkinsN.MelhamK., “Ethical Implications of the Use of Whole Genome Methods in Medical Research,”European Journal of Human Genetics18, no. 4 (2009): 398–403; MayerA. N.DimmockD. P.ArcaM. J.BickD. P.VerbskyJ. W.WortheyE. A.JacobH. J.MargolisD. A., “A Timely Arrival for Genomic Medicine,”Genetics in Medicine13, no. 3 (2011): 195–196; McGuireA. L.CaulfieldT.ChoM. K., “Research Ethics and the Challenge of Whole-Genome Sequencing,”Nature Reviews Genetics9, no. 2 (2008): 152–156, at 153.
13.
FerriE.BynnerJ.WadsworthM., Changing Britain, Changing Lives (London: Institute of Education Press, 2003).
14.
See Avard, supra note 2, s. 8.3.3.
15.
SamuëlJ.RiesN. M.MalkinD.KnoppersB. M., “Biobanks and Children: Comparative International Policies,” in Avard, at Chap. 4, 103–128, at 107; SamuëlJ.RiesN. M.MalkinD.KnoppersB. M., “Biobanks and Longitudinal Studies: Where Are the Children?”GenEdit6, no. 3 (2008): 1–8.
16.
RiesN.LeGrandeurJ.CaulfieldT., “Handling Ethical, Legal and Social Issues in Birth Cohort Studies Involving Genetic Research: Responses from Studies in Six Countries,”BMC Medical Ethics11, no. 1 (2010): 4–4.
17.
MadadiP.JolyY.AvardD.ChitayatD.SmithM.RossC.CarletonB.HaydenM.KorenG., “Communicating Pharmacogenetic Research Results to Breastfeeding Mothers Taking Codeine: A Pilot Study of Perceptions and Benefits,”Clinical Pharmacology & Therapeutics88, no. 6 (2010): 792–795.
18.
PartridgeA. H.BursteinH. J.GelmanR. S.MarcomP. K.WinerE. P., “Do Patients Participating in Clinical Trials Want to Know Study Results?”Journal of the National Cancer Institute95, no. 6 (2003): 491–492.
19.
MurphyJ.ScottJ.KaufmanD.GellerG.LeRoyL.HudsonK., “Public Expectations for Return of Results from Large-Cohort Genetic Research,”American Journal of Bioethics8, no. 11 (2008): 36–43.
European Medicines Agency (EMEA), Ethical Considerations for Clinical Trials on Medicinal Products Conducted with the Paediatric Population (Recommendations of the Ad Hoc Group for the Development of Implementing Guidelines for Directive 2001/20/Ec Relating to Good Clinical Practice in the Conduct of Clinical Trials on Medicinal Products for Human Use, 2008, available at <http://ec.europa.eu/health/fles/paediatrics/docs/paeds_ethics_consultation20060929_en.pdf> (last visited April 7, 2011), s. 19.1.
24.
Canadian Paediatric Society, “Ethical Issues in Health Research in Children,”Paediatric Child Health13, no. 8 (2008): 707–712 [hereinafter cited as Ethical Issues in Health Research in Children]; Canadian Paediatric Society and Canadian College of Medical Geneticists, “Guidelines for Genetic Testing of Healthy Children - Addendum,”Paediatric Child Health13, no. 4 (2008): 311–312; Réseau de Médecine Génétique Appliquée (RMGA), Statement of Principles for Genetic Research Involving Children, 2007), available at <http://www.rmga.qc.ca/fr/programs_and_forms> (last visited September 8, 2011).
25.
WilfondB. S.CarpenterK. J., “Incidental Findings in Pediatric Research,”Journal of Law, Medicine & Ethics36, no. 2 (2008): 332–340.
26.
Id.
27.
BhatiaS., “Late Effects among Survivors of Leukemia during Childhood and Adolescence,”Blood Cells, Molecules, and Diseases31, no. 1 (2003): 84–92; OeffingerK. C.HudsonM. M., “Long Term Complications Following Childhood and Adolescent Cancer: Foundations for Providing Risk Based Health Care for Survivors,”CA: A Cancer Journal for Clinicians54, no. 4 (2004): 208–236; OeffingerK.MertensA.SklarC.KawashimaT.HudsonM.MeadowsA.FriedmanD., “Childhood Cancer Survivor Study (2006) Chronic Health Conditions in Adult Survivors of Childhood Cancer,”New England Journal of Medicine355, no. 15 (2006): 1572–1582; ModyR.LiS.DoverD. C.SallanS.LeisenringW.OeffingerK. C.YasuiY.RobisonL. L.NegliaJ. P., “Twenty-Five-Year Follow-up among Survivors of Childhood Acute Lymphoblastic Leukemia: A Report from the Childhood Cancer Survivor Study,”Blood111, no. 12 (2008): 5515–5523.
28.
Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada and Social Sciences and Humanities Research Council of Canada, Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans, 2010, at Commentary s. 13.2.
29.
See WilfondCarpenter, supra note 25.
30.
Id.
31.
United Nations, Convention on the Rights of the Child, Geneva, 1989, at s. 3.1, available at <http://www2.ohchr.org/english/law/crc.htm> (last visited August 16, 2011); Civil Code of Quebec. S.Q. 1991, c. 64. 1994, s. 33.
32.
BorryP.Evers-KieboomsG.CornelM. C.ClarkeA.DierickxK., “Genetic Testing in Asymptomatic Minorsbackground Considerations Towards Eshg Recommendations,”European Journal of Human Genetics17, no. 6 (2009): 711–719.
33.
World Health Organization (WHO), Genetic Databases: Assessing the Benefits and the Impact on Human & Patients Rights, Geneva, 2003, available at <http://www.who.int/genomics/publications/en/index5.html> (last visited September 8, 2011); United Nations Educational Scientific and Cultural Organization (UNESCO), International Declaration on Human Genetic Data, Paris, 2003, available at <http://portal.unesco.org/en/ev.php-URL_ID=17720&URL_DO=DO_TOPIC&URL_SECTION=201.html> (last visited August 16, 2011); Human Genome Organization (HUGO), Statement on the Principled Conduct of Genetics Research, Singapore, 1995, available at <http://www.hugo-international.org/img/statmentontheprincipledconductofgeneticsresearch.pdf> (last visited August 16, 2011); Organisation for Economic Co-operation and Development, Guidelines on Human Biobanks and Genetic Research Databases, 2009, at s. 4.14, available at <http://www.oecd.org/dataoecd/41/47/44054609.pdf> (last visited August 16, 2011); Council of Europe, “Additional Protocol to the Convention on Human Rights and Biomedicine, Concerning Biomedical Research,”2005, at s. 27, available at <http://conventions.coe.int/Treaty/EN/Treaties/Html/195.htm> (last visited September 8, 2011); Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada and Social Sciences and Humanities Research Council of Canada, Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans, 2010, at s. 13.2–13.3, available at <http://www.pre.ethics.gc.ca/pdf/eng/tcps2/TCPS_2_FINAL_Web.pdf> (last visited September 8, 2011).
34.
PatenaudeA. F.BasiliL.FaircloughD. L.LiF. P., “Attitudes of 47 Mothers of Pediatric Oncology Patients toward Genetic Testing for Cancer Predisposition,”Journal of Clinical Oncology14, no. 2 (1996): 415–421.
35.
See Hens, supra note 10.
36.
See Avard, supra note 2.
37.
See WilfondCarpenter, supra note 25.
38.
See Hens, supra note 10.
39.
ElgerB. S.HardingT. W., “Testing Adolescents for a Hereditary Breast Cancer Gene (BRCA1): Respecting Their Autonomy Is in Their Best Interest,”Archives of Pediatrics and Adolescent Medicine154, no. 2 (2000): 113–119.
40.
BurkeW.DiekemaD. S., “Ethical Issues Arising from the Participation of Children in Genetic Research,”Journal of Pediatrics149, no. 1 (2006): S34–S38; BorryP.Evers-KieboomsG.CornelM. C.ClarkeA.DierickxK., “Genetic Testing in Asymptomatic Minorsbackground Considerations towards Eshg Recommendations,”European Journal of Human Genetics17, no. 6 (2009): 711–719; CodoriA. M.ZawackiK. L.PetersenG. M.MigliorettiD. L.BaconJ. A.TrimbathJ. D.BookerS. V.PicarelloK.GiardielloF. M., “Genetic Testing for Hereditary Colorectal Cancer in Children: Long Term Psychological Effects,”American Journal of Medical Genetics Part A116, no. 2 (2003): 117–128; see Ethical Issues in Health Research in Children, supra note 24.
41.
European Society of Human Genetics, Genetic Testing in Asymptomatic Minors, 2009, available at <https://www.eshg.org/fleadmin/eshg/documents/TestingInMinorsRecommendations.pdf> (last visited April 8, 2011); BorryP.StultiënsL.NysH.CassimanJ., “Presymptomatic and Predictive Genetic Testing in Minors: A Systematic Review of Guidelines and Position Papers,”Clinical Genetics70, no. 5 (2006): 374–381.
42.
See Ethical Issues in Health Research in Children, supra note 24; IsasiR. M.KnoppersB. M., “Beyond the Permissibility of Embryonic and Stem Cell Research: Substantive Requirements and Procedural Safeguards,”Human Reproduction21, no. 10 (2006): 2474–2481; Réseau de Médecine Génétique Appliquée (RMGA), Statement of Principles for Genetic Research Involving Children, 2007), available at <https://rmga.ca/files/attachments/0000/0057/FINAL_RMGA-Policy_Statement_on_Genetic_Research_with_Children.pdf> (last visited November 1, 2010).
43.
See Canadian Institutes of Health Research, supra note 28, at Commentary s. 13.2.
44.
See Canadian Paediatric Society and Canadian College of Medical Geneticists, supra note 24.
45.
Id.
46.
Id.
47.
See RMGA, supra note 42; FabsitzR. R.McGuireA.SharpR. R.PuggalM.BeskowL. M.BieseckerL. G.BookmanE., “Ethical and Practical Guidelines for Reporting Genetic Research Results to Study Participants,”Circulation: Cardiovascular Genetics3, no. 6 (2010): 574–580, at 575.
48.
See BurkeDiekema, supra note 40.
49.
European Society of Human Genetics, Genetic Testing in Asymptomatic Minors, 2009, available at <https://www.eshg.org/fleadmin/eshg/documents/TestingInMinorsRecommendations.pdf> (last visited August 15, 2011), at Recommendation 7; Canadian Paediatric Society and Canadian College of Medical Geneticists, “Guidelines for Genetic Testing of Healthy Children - Addendum,”Paediatric Child Health13, no. 4 (2008): 311–312, at 45.
50.
Id. (European Society of Human Genetics).
51.
Id., at Recommendations 10 and 11.
52.
See Hens, supra note 10.
53.
WilfondB.RossL. F., “From Genetics to Genomics: Ethics, Policy, and Parental Decision-Making,”Journal of Pediatric Psychology34, no. 6 (2009): 639–647, at 644.
54.
See Madadi, supra note 17.
55.
See Ethical Issues in Health Research in Children, supra note 24.
56.
ForsbergJ. S.HanssonM. G.ErikssonS., “Changing Perspectives in Biobank Research: From Individual Rights to Concerns about Public Health Regarding the Return of Results,”European Journal of Human Genetics17, no. 12 (2009): 1544–1549, at 1545; see Hens, supra note 10.
Rosas-BlumE.ShirsatP.LeinerM., “Communicating Genetic Information: A Difficult Challenge for Future Pediatricians,”BMC Medical Education7, no. 1 (2007): 17–24.
60.
BaarsM. J. H.HennemanL.ten KateL. P., “Deficiency of Knowledge of Genetics and Genetic Tests among General Practitioners, Gynecologists, and Pediatricians: A Global Problem,”Genetics in Medicine7, no. 9 (2005): 605–610.
61.
See Canadian Paediatric Society, supra note 44.
62.
BookmanE. B.LangehorneA. A.EckfieldtJ. H.GlassK. C.JarvikG. P.KlagM.KoskiG., “Reporting Genetic Results in Research Studies: Summary and Recommendations of an Nhlbi Working Group,”American Journal of Medical Genetics Part A140, no. 10 (2006): 1033–1040.
63.
MeachamM. C.StarksH.BurkeW.EdwardsK., “Researcher Perspectives on Disclosure of Incidental Findings in Genetic Research,”Journal of Empirical Research on Human Research Ethics5, no. 3 (2010): 31–41.
64.
See Fabsitz, supra note 47, at 577; Canadian Paediatric Society and Canadian College of Medical Geneticists, supra note 44; Bookman, supra note 62.
65.
See Canadian Institutes of Health Research, supra note 28.
66.
PHG Foundation, Public Health in an Era of Genome-Based and Personalised Medicine, Cambridge, 2010, available at <http://www.phgfoundation.org/file/6616/> (last visited August 15, 2011).
67.
United Nations Educational Scientific and Cultural Organization (UNESCO), Report on Confidentiality and Genetic Data, Paris, 2000, at para. 51, available at <http://unesdoc.unesco.org/images/0013/001323/132334e.pdf> (last visited August 15, 2011).
68.
Canadian Institutes of Health Research, supra note 28, at 181.
69.
See RiesLeGrandeurCaulfield, supra note 16.
70.
See Ethical Issues in Health Research in Children, supra note 24.
71.
HunterA. G. W.SharpeN.MullenM.MeschinoW. S., “Ethical, Legal, and Practical Concerns about Recontacting Patients to Inform Them of New Information: The Case in Medical Genetics,”American Journal of Medical Genetics103, no. 4 (2001): 265–276.
72.
See WilfondCarpenter, supra note 25, at 337.
73.
FernandezC. V.SantorD.WeijerC.StrahlendorfC.MoghrabiA.PentzR.GaoJ.KodishE., “The Return of Research Results to Participants: Pilot Questionnaire of Adolescents and Parents of Children with Cancer,”Pediatric Blood & Cancer48, no. 4 (2007): 441–446.
74.
See WilfondCarpenter, supra note 25.
75.
MayerA. N.DimmockD. P.ArcaM. J.BickD. P.VerbskyJ. W.WortheyE. A.JacobH. J.MargolisD. A., “A Timely Arrival for Genomic Medicine,”Genetics in Medicine13, no. 3 (2011): 195–196.